TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -10 | -3 | 4 | 3 | 1 | 33 | 5 |
| P | %wins | 0 | 0 | 100 | 100 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/1/24 16:47 | 1/30/24 | AVBP | Arrivent Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hillhouse Investment Management, Ltd. | E9 | T | P.d | 10,000 | 18.00 | 0 | 556 | 14 | 4,485 | I | |||||||||||||||
11/15/17 16:32 | 11/13/17 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hillhouse Capital Management, Ltd. | E9 | T | P.d | 20,000 | 14.00 | 0 | 1,429 | 68 | 3,527 | I | |||||||||||||||
2/10/16 16:32 | 2/8/16 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Hillhouse Capital Management, Ltd. | E9 | T | P.d | 0 | 0.00 | 9 | 9,100 | 30 | 39,727 | I | -9 | -10 | -3 | 4 | 3 | 1 | 33 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |